The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features

被引:11
作者
Cykowski, Matthew D. [1 ]
Allen, Richard A. [1 ]
Kanaly, Angela C. [1 ]
Fung, Kar-Ming [1 ,2 ]
Marshall, Roxanne [3 ]
Perry, Arie [3 ]
Stolzenberg, Ethan D. [1 ]
Dunn, S. Terence [1 ,4 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA
[2] Oklahoma City Vet Adm, Med Ctr, Dept Pathol, Oklahoma City, OK USA
[3] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA
[4] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73190 USA
关键词
IDH; BRAF-KIAA1549; BRAF V600E; TP53; p16; Pilocytic astrocytoma; Childhood glioma; ISOCITRATE DEHYDROGENASE 1; P53; GENE-MUTATIONS; LOW-GRADE GLIOMAS; TP53; MUTATIONS; IDH2; HIGH-FREQUENCY; BRAIN-TUMORS; ACTIVATION; PREDICTS; PATHWAY;
D O I
10.1007/s11060-013-1249-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Rare pilocytic astrocytomas (PA) have atypical histologic and clinicoradiologic features that raise the differential diagnosis of glioblastoma. Whether ancillary studies can supplement histopathologic examination in placing these cases accurately on the spectrum of WHO Grade I PA to higher-grade glioma is not always clear, partly because these cases are not common. Here, ten PAs with atypical clinicoradiologic and histologic features and six pediatric glioblastoma multiforme (pGBMs) were analyzed for BRAF V600E, IDH1, IDH2, and TP53 mutations. Ki-67, p53, and p16 protein expression were also examined by immunohistochemistry. BRAF-KIAA1549 fusion status was assessed in the PA subgroup. The rate of BRAF-KIAA1549 fusion was high in these PAs (5/7 tumors) including four extracerebellar examples. A single BRAF V600E mutation was identified in the fusion-negative extracerebellar PA of a very young child who succumbed to the disease. TP53 mutations were present only in malignant gliomas, including three pGBMs and one case designated as PA with anaplastic features (with consultation opinion of pGBM). IDH1 and IDH2 were wild type in all cases, consistent with earlier findings that IDH mutations are not typical in high-grade gliomas of patients a parts per thousand currency sign14 years of age. Immunohistochemical studies showed substantial overlap in Ki-67 labeling indices, an imperfect correlation between p53 labeling and TP53 mutation status, and complete p16 loss in only two pGBMs but in no PAs. These results suggest that (a) BRAF-KIAA1549 fusion may be common in PAs with atypical clinicoradiologic and histologic features, including those at extracerebellar sites, (b) BRAF V600E mutation is uncommon in extracerebellar PAs, and (c) TP53 mutation analysis remains a valuable tool in identifying childhood gliomas that will likely behave in a malignant fashion.
引用
收藏
页码:477 / 486
页数:10
相关论文
共 35 条
  • [1] Burger PC., 2002, Surgical Pathology of the Nervous System and its Coverings, VFourth
  • [2] A Sensitive and Specific Diagnostic Panel to Distinguish Diffuse Astrocytoma From Astrocytosis: Chromosome 7 Gain With Mutant Isocitrate Dehydrogenase 1 and p53
    Camelo-Piragua, Sandra
    Jansen, Michael
    Ganguly, Aniruddha
    Kim, James ChulMin
    Cosper, Arjola K.
    Dias-Santagata, Dora
    Nutt, Catherine L.
    Iafrate, A. John
    Louis, David N.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2011, 70 (02) : 110 - 115
  • [3] Pyrosequencing of IDH1 and IDH2 Mutations in Brain Tumors and Non-neoplastic Conditions
    Cykowski, Matthew D.
    Allen, Richard A.
    Fung, Kar-Ming
    Harmon, Michael A.
    Dunn, Samuel T.
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 2012, 21 (04) : 214 - 220
  • [4] COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
    Forbes, Simon A.
    Bindal, Nidhi
    Bamford, Sally
    Cole, Charlotte
    Kok, Chai Yin
    Beare, David
    Jia, Mingming
    Shepherd, Rebecca
    Leung, Kenric
    Menzies, Andrew
    Teague, Jon W.
    Campbell, Peter J.
    Stratton, Michael R.
    Futreal, P. Andrew
    [J]. NUCLEIC ACIDS RESEARCH, 2011, 39 : D945 - D950
  • [5] The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma
    Frank, AJ
    Hernan, R
    Hollander, A
    Lindsey, JC
    Lusher, ME
    Fuller, CE
    Clifford, SC
    Gilbertson, RJ
    [J]. MOLECULAR BRAIN RESEARCH, 2004, 121 (1-2): : 137 - 140
  • [6] BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
    Hawkins, Cynthia
    Walker, Erin
    Mohamed, Nequesha
    Zhang, Cindy
    Jacob, Karine
    Shirinian, Margret
    Alon, Noa
    Kahn, Daniel
    Fried, Iris
    Scheinemann, Katrin
    Tsangaris, Elena
    Dirks, Peter
    Tressler, Robert
    Bouffet, Eric
    Jabado, Nada
    Tabori, Uri
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (14) : 4790 - 4798
  • [7] High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors
    Hayes, VM
    Dirven, CMF
    Dam, A
    Verlind, E
    Molenaar, WM
    Mooij, JJA
    Hofstra, RMW
    Buys, CHCM
    [J]. BRAIN PATHOLOGY, 1999, 9 (03) : 463 - 467
  • [8] Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas
    Horbinski, Craig
    Nikiforova, Marina N.
    Hagenkord, Jill M.
    Hamilton, Ronald L.
    Pollack, Ian F.
    [J]. NEURO-ONCOLOGY, 2012, 14 (06) : 777 - 789
  • [9] Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas
    Horbinski, Craig
    Hamilton, Ronald L.
    Nikiforov, Yuri
    Pollack, Ian F.
    [J]. ACTA NEUROPATHOLOGICA, 2010, 119 (05) : 641 - 649
  • [10] Ishii N, 1998, INT J CANCER, V76, P797, DOI 10.1002/(SICI)1097-0215(19980610)76:6<797::AID-IJC5>3.3.CO